Tags

Type your tag names separated by a space and hit enter

[Yellow fever vaccination: update on rare and severe adverse effects].
Med Mal Infect. 2009 Apr; 39(4):234-41.MM

Abstract

Over 500million people live in yellow fever (YF) endemic areas and more than 3million travel to endemic countries every year. Prevention against YF, caused by the YF virus, an arbovirus, can only be efficiently obtained by active immunization. The vaccine is well tolerated and severe adverse events are very rare. Exceptionally, YF vaccination may result in serious adverse events, such as viscerotropic and neurotropic diseases, sometimes with a fatal outcome. These rare serious adverse advents are reviewed with their potential risk factors, such as advanced age or history of thymus disease. The benefit/risk ratio remains in favour of vaccination, although the decision to offer yellow fever vaccination, especially to persons 60years of age or older, should be evaluated according to the planned trip. Additional research investigations should be made on the host immune response since this response is considered to be at the origin of these severe adverse events.

Authors+Show Affiliations

Service de médecine interne et tropicale, hôpital Saint-André, centre hospitalier universitaire de Bordeaux, 1, rue Jean-Burguet, 33000 Bordeaux, France. marie-catherine.receveur@chu-bordeaux.frNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

19167852

Citation

Receveur, M-C, et al. "[Yellow Fever Vaccination: Update On Rare and Severe Adverse Effects]." Medecine Et Maladies Infectieuses, vol. 39, no. 4, 2009, pp. 234-41.
Receveur MC, Bruyand M, Pistone T, et al. [Yellow fever vaccination: update on rare and severe adverse effects]. Med Mal Infect. 2009;39(4):234-41.
Receveur, M. C., Bruyand, M., Pistone, T., & Malvy, D. (2009). [Yellow fever vaccination: update on rare and severe adverse effects]. Medecine Et Maladies Infectieuses, 39(4), 234-41. https://doi.org/10.1016/j.medmal.2008.11.013
Receveur MC, et al. [Yellow Fever Vaccination: Update On Rare and Severe Adverse Effects]. Med Mal Infect. 2009;39(4):234-41. PubMed PMID: 19167852.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Yellow fever vaccination: update on rare and severe adverse effects]. AU - Receveur,M-C, AU - Bruyand,M, AU - Pistone,T, AU - Malvy,D, Y1 - 2009/01/23/ PY - 2007/10/08/received PY - 2008/08/25/revised PY - 2008/11/12/accepted PY - 2009/1/27/entrez PY - 2009/1/27/pubmed PY - 2009/7/29/medline SP - 234 EP - 41 JF - Medecine et maladies infectieuses JO - Med Mal Infect VL - 39 IS - 4 N2 - Over 500million people live in yellow fever (YF) endemic areas and more than 3million travel to endemic countries every year. Prevention against YF, caused by the YF virus, an arbovirus, can only be efficiently obtained by active immunization. The vaccine is well tolerated and severe adverse events are very rare. Exceptionally, YF vaccination may result in serious adverse events, such as viscerotropic and neurotropic diseases, sometimes with a fatal outcome. These rare serious adverse advents are reviewed with their potential risk factors, such as advanced age or history of thymus disease. The benefit/risk ratio remains in favour of vaccination, although the decision to offer yellow fever vaccination, especially to persons 60years of age or older, should be evaluated according to the planned trip. Additional research investigations should be made on the host immune response since this response is considered to be at the origin of these severe adverse events. SN - 0399-077X UR - https://www.unboundmedicine.com/medline/citation/19167852/[Yellow_fever_vaccination:_update_on_rare_and_severe_adverse_effects]_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0399-077X(08)00429-0 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.